Foghorn Therapeutics Inc.
FHTX
Revenue
2.86M
▼-4.95M▼-63.42%
3 Months ChangeAssets
283.98M
▼-24.39M▼-7.91%
3 Months ChangeLiabilities
329.51M
▼-7.15M▼-2.12%
3 Months ChangeFree Cash Flow
-29.45M
▲2.37M▲7.45%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-10
Form 8-K
ID: 0001628280-24-042630
2024-08-08
Form 10-Q
ID: 0001628280-24-035867
2024-08-08
Form 8-K
ID: 0001628280-24-035864
2024-06-26
Form 8-K
ID: 0001628280-24-030137
2024-06-03
Form 8-K
ID: 0001628280-24-026294
2024-05-23
Form 8-K
ID: 0001628280-24-024811
2024-05-22
Form 8-K
ID: 0001193125-24-144934
2024-05-20
Form 8-K
ID: 0001628280-24-024217
2024-05-06
Form 8-K
ID: 0001628280-24-020698
2024-05-06
Form 10-Q
ID: 0001628280-24-020455